Bay Area's Principia Biopharma Scores $765M MS Licensing Deal With Drug Giant Sanofi Post author:Sam Post published:November 8, 2017 Post category:BioPharma Sanofi will write a check for $40 million upfront. Source: BioSpace You Might Also Like NeuroDigm Uses Tissue Repair In An Innovative Nerve Pain Model May 11, 2017 Oncolytics Biotech, Adlai Nortye Forge $86.6M Reolysin Deal November 16, 2017 Why the Best is Yet to Come for This Tiny Massachusetts Biotech November 27, 2017